# A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus

> **NCT04882878** · PHASE2 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 228 (actual)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **OTHER:** Placebo
- **DRUG:** Nipocalimab
- **DRUG:** Standard-of-care treatment

## Key facts

- **NCT ID:** NCT04882878
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-20
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-12-26
- **Target enrollment:** 228 (ACTUAL)
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04882878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04882878, "A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04882878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*